These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9756771)

  • 1. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
    McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
    J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
    Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin in the therapy of experimental pneumococcal meningitis.
    Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
    Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
    Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
    J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication.
    Lister PD
    Antimicrob Agents Chemother; 2002 Jan; 46(1):69-74. PubMed ID: 11751113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
    Takahata M; Yamada H; Morita T; Furubou S; Minami S; Todo Y; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1760-5. PubMed ID: 12019087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.
    Scheld WM; Sande MA
    J Clin Invest; 1983 Mar; 71(3):411-9. PubMed ID: 6826714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
    Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
    J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.